WASHINGTON UNIVERSITY recently filed their 13F report for the fourth quarter of 2022, which ended on 2022-12-31.
The 13F report details which stocks were in a guru’s equity portfolio at the end of the quarter, though investors should note that these filings are limited in scope, containing only a snapshot of long positions in U.S.-listed stocks and American depository receipts as of the quarter’s end. They are not required to include international holdings, short positions or other types of investments. Still, even this limited filing can provide valuable information.
CAMPUS BOX NUMBER 1058 ST LOUIS, MO 63130
As of the latest 13F report, the guru’s equity portfolio contained 7 stocks valued at a total of $340.00Mil. The top holdings were CPNG(33.56%), LNW(30.74%), and NU(20.47%).
According to GuruFocus data, these were WASHINGTON UNIVERSITY’s top five trades of the quarter.
Nu Holdings Ltd
During the quarter, WASHINGTON UNIVERSITY bought 3,128,025 shares of NYSE:NU for a total holding of 17,066,179. The trade had a 4.65% impact on the equity portfolio. During the quarter, the stock traded for an average price of $4.59.
On 01/30/2023, Nu Holdings Ltd traded for a price of $4.3752 per share and a market cap of $20.50Bil. The stock has returned -35.19% over the past year.
GuruFocus gives the company a financial strength rating of 5 out of 10 and a profitability rating of 1 out of 10.
In terms of valuation, Nu Holdings Ltd has a price-book ratio of 4.33 and a price-sales ratio of 8.56.
Vacasa Inc
The guru sold out of their 1,361,470-share investment in NAS:VCSA. Previously, the stock had a 1.45% weight in the equity portfolio. Shares traded for an average price of $3.47 during the quarter.
On 01/30/2023, Vacasa Inc traded for a price of $1.725 per share and a market cap of $407.71Mil. The stock has returned -71.70% over the past year.
GuruFocus gives the company a financial strength rating of 5 out of 10 and a profitability rating of 1 out of 10.
In terms of valuation, Vacasa Inc has a price-book ratio of 1.01, a EV-to-Ebitda ratio of -7.36 and a price-sales ratio of 0.33.
Ginkgo Bioworks Holdings Inc
The guru sold out of their 1,102,044-share investment in NYSE:DNA. Previously, the stock had a 0.97% weight in the equity portfolio. Shares traded for an average price of $2.98 during the quarter.
On 01/30/2023, Ginkgo Bioworks Holdings Inc traded for a price of $1.87 per share and a market cap of $3.84Bil. The stock has returned -62.47% over the past year.
GuruFocus gives the company a financial strength rating of 6 out of 10 and a profitability rating of 1 out of 10.
In terms of valuation, Ginkgo Bioworks Holdings Inc has a price-book ratio of 2.15, a EV-to-Ebitda ratio of -0.77 and a price-sales ratio of 5.62.
NGM Biopharmaceuticals Inc
The guru sold out of their 44,314-share investment in NAS:NGM. Previously, the stock had a 0.21% weight in the equity portfolio. Shares traded for an average price of $15.14 during the quarter.
On 01/30/2023, NGM Biopharmaceuticals Inc traded for a price of $5.035 per share and a market cap of $411.49Mil. The stock has returned -67.33% over the past year.
GuruFocus gives the company a financial strength rating of 7 out of 10 and a profitability rating of 2 out of 10.
In terms of valuation, NGM Biopharmaceuticals Inc has a price-book ratio of 1.44, a EV-to-Ebitda ratio of -0.82 and a price-sales ratio of 6.79.
The price-to-GF Value ratio is 0.48, earning the stock a GF Value rank of 4.
CNFinance Holdings Ltd
The guru sold out of their 26,509-share investment in NYSE:CNF. Previously, the stock had a 0.03% weight in the equity portfolio. Shares traded for an average price of $2.52 during the quarter.
On 01/30/2023, CNFinance Holdings Ltd traded for a price of $1.62 per share and a market cap of $111.10Mil. The stock has returned -46.77% over the past year.
GuruFocus gives the company a financial strength rating of 2 out of 10 and a profitability rating of 3 out of 10.
In terms of valuation, CNFinance Holdings Ltd has a price-earnings ratio of 0.86, a price-book ratio of 0.20, a price-earnings-to-growth (PEG) ratio of 0.03 and a price-sales ratio of 1.38.
The price-to-GF Value ratio is 0.38, earning the stock a GF Value rank of 4.
Please note, the numbers and facts quoted are as of the writing of this article and may not factor in the latest trading data or company announcements.
When GuruFocus covers insider information, we only track open market or the private purchase and sale of common stock with the transaction code of P or S. Therefore, all the transactions mentioned in this article are only the ones with transaction code of P or S.
Want to provide feedback on this article? Have questions or concerns? Get in touch with us here, or email us at [email protected]!
This article is general in nature and does not represent the opinions of GuruFocus or any of its affiliates. This article is not intended to be financial advice, nor does it constitute investment advice or recommendations. It was written without regard to your individual situation or financial goals. We aim to bring you fundamental, data-driven analysis, The information on this site is in no way guaranteed for completeness, accuracy or in any other way.
